PBM Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Valuation Metrics

The current forward P/E ratio for Psyence Biomedical Ltd (PBM.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Psyence Biomedical Ltd 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

0.00

Current PE

0.00

Overvalued PE

0.00

Undervalued PE

0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

0.00

Current PS

0.00

Overvalued PS

0.00

Undervalued PS

0.00

Financials

Annual

Quarterly

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

PBM News & Events

Events Timeline

No data

News

3.5

01-05Globenewswire

Psyence BioMed Becomes First Nasdaq Company to Produce GMP-Compliant Ibogaine HCl

3.5

01-05Newsfilter

Psyence BioMed Achieves First GMP-Compliant High-Purity Ibogaine Production on Nasdaq

3.5

2025-12-19Newsfilter

Kraig Biocraft Laboratories Transitions to Spider Silk Commercialization with 22% Yield Increase

People Also Watch

Frequently Asked Questions

What is Psyence Biomedical Ltd (PBM) stock price today?

The current price of PBM is 0.8 USD — it has increased 4.17 % in the last trading day.

What is Psyence Biomedical Ltd (PBM)'s business?

Psyence Biomedical Ltd is a multi-asset, vertically integrated biopharmaceutical company specializing in psychedelic-based therapeutics. The Company is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. It is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.

What is the price predicton of PBM Stock?

Wall Street analysts forecast PBM stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for PBM is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Psyence Biomedical Ltd (PBM)'s revenue for the last quarter?

Psyence Biomedical Ltd revenue for the last quarter amounts to -1.51M USD, increased 30.18 % YoY.

What is Psyence Biomedical Ltd (PBM)'s earnings per share (EPS) for the last quarter?

Psyence Biomedical Ltd. EPS for the last quarter amounts to -251456.00 USD, decreased % YoY.

What changes have occurred in the market's expectations for Psyence Biomedical Ltd (PBM)'s fundamentals?

The market is revising No Change the revenue expectations for PBM for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -78.38%.

How many employees does Psyence Biomedical Ltd (PBM). have?

Psyence Biomedical Ltd (PBM) has 12 emplpoyees as of January 09 2026.

What is Psyence Biomedical Ltd (PBM) market cap?

Today PBM has the market capitalization of 1.44M USD.